mRNA vaccines induce rapid antibody responses in mice
Abstract mRNA vaccines can be developed and produced quickly, making them prime candidates for immediate outbreak responses. Furthermore, clinical trials have demonstrated rapid protection following mRNA vaccination. Thus, we sought to investigate how quickly mRNA vaccines elicit antibody responses...
Principais autores: | Makda S. Gebre, Susanne Rauch, Nicole Roth, Janina Gergen, Jingyou Yu, Xiaowen Liu, Andrew C. Cole, Stefan O. Mueller, Benjamin Petsch, Dan H. Barouch |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
Nature Portfolio
2022-08-01
|
coleção: | npj Vaccines |
Acesso em linha: | https://doi.org/10.1038/s41541-022-00511-y |
Registros relacionados
-
mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents
por: Susanne Rauch, et al.
Publicado em: (2021-04-01) -
Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses
por: Nicole Roth, et al.
Publicado em: (2022-08-01) -
mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice
por: Charlie Fricke, et al.
Publicado em: (2024-12-01) -
Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models
por: Nicole Roth, et al.
Publicado em: (2023-01-01) -
Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models
por: Björn Corleis, et al.
Publicado em: (2023-02-01)